Cronos Group CRON Stock Analysis and what to watch fro with CRON Stock

K36 Therapeutics raises $70M in Series B to fund multiple myeloma research

K36 Therapeutics raised $70 million to help fund an ongoing clinical trial for its lead and only candidate, an oral multiple myeloma treatment. The Cambridge,

June 29, 2023

When AI becomes a tool to fight insurance denials

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in

December 12, 2024

Why The Time Is Now for Healthcare Provider Cloud Migration

Rick Froehlich, President and Chief Executive Officer at ClearDATA It’s no secret that healthcare is a slow-moving industry. Its hesitancy to change has played out

August 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.